GlassScriptPhysician profile
Eiluned A Hogenson
NPI 1558376954
$604.70
in general payments reported to CMS, 2019-2025
8 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $152 · 2023: $125 · 2024: $178 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $453.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $250.00 | 2023-2024 | Biktarvy |
| Sage Therapeutics, LLC | $116.53 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $82.21 | 2022-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $74.05 | 2022 | |
| Supernus Pharmaceuticals, INC. | $23.76 | 2025 | Qelbree |
| Pfizer INC. | $21.64 | 2025 | |
| Evofem Biosciences, INC. | $18.43 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eiluned Hogenson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.